| 1. |
- Tran, K. B., et al.
(författare)
-
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019
- 2022
-
Ingår i: Lancet. - 0140-6736. ; 400:10352, s. 563-591
-
Tidskriftsartikel (refereegranskat)abstract
- Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Adamo, Marianna, et al.
(författare)
-
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
- 2024
-
Ingår i: European Journal of Heart Failure. - : WILEY. - 1388-9842 .- 1879-0844.
-
Tidskriftsartikel (refereegranskat)abstract
- Right-sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death. While medical therapy for right-sided heart failure is limited, treatment options for tricuspid regurgitation include surgery and, based on recent developments, several transcatheter interventions. However, the patients who might benefit from tricuspid valve interventions are yet unknown, as is the ideal time for these treatments given the paucity of clinical evidence. In this context, it is crucial to elucidate aetiology and pathophysiological mechanisms leading to right-sided heart failure and tricuspid regurgitation in order to recognize when tricuspid regurgitation is a mere bystander and when it can cause or contribute to heart failure progression. Notably, early identification of right heart failure and tricuspid regurgitation may be crucial and optimal management requires knowledge about the different mechanisms and causes, clinical course and presentation, as well as possible treatment options. The aim of this clinical consensus statement is to summarize current knowledge about epidemiology, pathophysiology and treatment of tricuspid regurgitation in right-sided heart failure providing practical suggestions for patient identification and management.
|
|
| 5. |
- Kharitonov, D. S., et al.
(författare)
-
Corrosion of AD31 (AA6063) Alloy in Chloride-Containing Solutions
- 2018
-
Ingår i: Protection of Metals and Physical Chemistry of Surfaces. - : MAIK NAUKA/INTERPERIODICA/SPRINGER. - 2070-2051. ; 54:2, s. 291-300
-
Tidskriftsartikel (refereegranskat)abstract
- Corrosion of AD31 (AA6063) alloy in neutral 0.05 M NaCl solutions is investigated via scanningprobe microscopy, linear-sweep voltammetry, and electrochemical-impedance spectroscopy. Al−Fe−Si−Mg intermetallic particles are determined to prevail in the structure of alloy and act as local cathodes. Intermodulation electrostatic-force-microscopy imaging shows that their Volta potential differs by 570 mV from that of the host aluminum matrix, making the alloy prone to localized corrosion. We show that the corrosion of alloy in the studied electrolyte mainly develops locally and results in pitting, with charge transfer being the limiting stage of the process. A mechanism of corrosion of the AD31 (AA6063) alloy in neutral chloride-containing solutions is proposed.
|
|
| 6. |
- Mullens, Wilfried, et al.
(författare)
-
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)
- 2024
-
Ingår i: European Journal of Heart Failure. - : WILEY. - 1388-9842 .- 1879-0844.
-
Tidskriftsartikel (refereegranskat)abstract
- Implantable devices form an integral part of the management of patients with heart failure (HF) and provide adjunctive therapies in addition to cornerstone drug treatment. Although the number of these devices is growing, only few are supported by robust evidence. Current devices aim to improve haemodynamics, improve reverse remodelling, or provide electrical therapy. A number of these devices have guideline recommendations and some have been shown to improve outcomes such as cardiac resynchronization therapy, implantable cardioverter-defibrillators and long-term mechanical support. For others, more evidence is still needed before large-scale implementation can be strongly advised. Of note, devices and drugs can work synergistically in HF as improved disease control with devices can allow for further optimization of drug therapy. Therefore, some devices might already be considered early in the disease trajectory of HF patients, while others might only be reserved for advanced HF. As such, device therapy should be integrated into HF care programmes. Unfortunately, implementation of devices, including those with the greatest evidence, in clinical care pathways is still suboptimal. This clinical consensus document of the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) describes the physiological rationale behind device-provided therapy and also device-guided management, offers an overview of current implantable device options recommended by the guidelines and proposes a new integrated model of device therapy as a part of HF care.
|
|
| 7. |
- Fargas, Gemma, et al.
(författare)
-
Oxidation behavior of TI-6Al-4V alloy exposed to isothermal and cyclic thermal treatments
- 2017
-
Ingår i: Proceedings of the conference METAL 2017. - Ostrava : TANGER Ltd.. - 9788087294796 ; , s. 1573-1579
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- One of the most common titanium alloys for aerospace industry is Ti-6Al-4V (usually designed as Ti-64) which is used for manufacturing aero-engine components, such as fan discs, compressor discs, blades andstators. The maximum service temperature for this alloy is limited partly because of degradation of mechanical properties at elevated temperatures (above 480 ºC). During the first stage of oxidation the oxidescale is protective, whereas after prolonged oxidation time it loses its protective nature and favours higher diffusion of oxygen through the oxide. In the present study, cyclic thermal treatments were performed in air at 500 and 700 ºC, up to 500 hours, and compared with similar studies carried out on isothermal oxidation conditions. The evolution of the surface oxidation was analyzed by metallographic techniques and X-ray diffraction, together with a detailed advanced characterization of the microstructure by Scanning Electron Microscopy and Focus Ions Beam. The results point out that the cyclic thermal treatments induced a strong increase of the weight gain compared to isothermal treatments. The analysis of the oxide scale revealed not only the presence of rutile, at 700 ºC, but also anatase and TiOx at 500 ºC for both isothermal and cyclic thermal treatments. At 700 ºC, thermal stress caused by cyclic thermal treatments promoted the fracture of the oxide after the first 20 hours.
|
|
| 8. |
- Kharitonov, Dmitry S., et al.
(författare)
-
Surface and corrosion properties of AA6063-T5 aluminum alloy in molybdate-containing sodium chloride solutions
- 2020
-
Ingår i: Corrosion Science. - : Elsevier Ltd. - 0010-938X .- 1879-0496. ; 171
-
Tidskriftsartikel (refereegranskat)abstract
- Corrosion properties of aluminum alloy AA6063-T5 were investigated in molybdate-containing NaCl solutions. Electrochemical, microscopic, and spectroscopic experiments were utilized to examine the mechanism of corrosion inhibition by molybdates. SEM-EDX, magnetic force, and intermodulation electrostatic force microscopy data suggested that the inhibition initiation preferentially occurred over Fe-rich cathodic IMPs. Spectroscopic measurements demonstrated that the formed surface layer consists of mixed Mo(VI, V, IV) species. This layer provided inhibition with an efficiency of ∼90% after 4 h of exposure. High efficacy of ∼70% was achieved even after one week of exposure. A two-step oxidation-reduction mechanism of corrosion inhibition by aqueous molybdates was proposed. © 2020 The Authors
|
|
